Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 37

Results For "THA"

7957 News Found

Thermo Fisher and Singapore’s PRECISE launch major proteomics push in 100,000-person study
News | April 14, 2026

Thermo Fisher and Singapore’s PRECISE launch major proteomics push in 100,000-person study

The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation


GoodRx partners with Eli Lilly to expand access to new oral GLP-1 Foundayo & Zepbound KwikPen
News | April 14, 2026

GoodRx partners with Eli Lilly to expand access to new oral GLP-1 Foundayo & Zepbound KwikPen

GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access


Kauvery Hospital conducts 4th edition of ECG Masterclass 2026; 400+ medical professionals attend
Hospitals | April 14, 2026

Kauvery Hospital conducts 4th edition of ECG Masterclass 2026; 400+ medical professionals attend

Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”


India Pharma 2026 showcases sectoral transformation through four key plenary discussions
Policy | April 14, 2026

India Pharma 2026 showcases sectoral transformation through four key plenary discussions

Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals


India must build its own agile biopharma innovation model: ICMR DG Dr Rajiv Bahl
Policy | April 14, 2026

India must build its own agile biopharma innovation model: ICMR DG Dr Rajiv Bahl

At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace


CDSCO reforms cut trial approval timelines by over 50%: DCGI Dr Rajeev Raghuvanshi
Drug Approval | April 14, 2026

CDSCO reforms cut trial approval timelines by over 50%: DCGI Dr Rajeev Raghuvanshi

Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews


FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review
Drug Approval | April 14, 2026

FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review

The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis


Eli Lilly posts strong Phase 3 win for Jaypirca combo in blood cancer trial
Clinical Trials | April 14, 2026

Eli Lilly posts strong Phase 3 win for Jaypirca combo in blood cancer trial

Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors


NASA’s Artemis II mission to on board Opella’s Dulcolax for lunar orbit mission
News | April 14, 2026

NASA’s Artemis II mission to on board Opella’s Dulcolax for lunar orbit mission

A brand from Opella will be part of the official NASA astronaut formulary


Roche wins CE mark for blood-based MS brain damage test
News | April 14, 2026

Roche wins CE mark for blood-based MS brain damage test

The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain